SMTL ID : 7dhl.1

Crystal structure of FGFR3 in complex with pyrimidine derivative

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.57 Å

Oligo State

monomer

Ligands

1 x H6X: 5-[2-(3,5-dimethoxyphenyl)ethyl]-N-[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidin-2-amine(Non-covalent)

H6X.1: 16 residues within 4Å: Chain A: L.32, V.40, A.60, K.62, E.79, M.83, I.93, V.109, E.110, Y.111, A.112, G.115, L.178, A.188, D.189, F.190 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:A.60, A:I.93, A:V.109, A:Y.111, A:L.178, A:A.188 Hydrogen bonds: A:E.79, A:A.112, A:A.112, A:D.189 Water bridges: A:N.116

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kuriwaki, I. et al., Synthesis and structure-activity relationships of pyrimidine derivatives as potent and orally active FGFR3 inhibitors with both increased systemic exposure and enhanced in vitro potency. Bioorg.Med.Chem. (2021)

Release Date

2021-02-03

Peptides

Fibroblast growth factor receptor 3: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Fibroblast growth factor receptor 3

Related Entries With Identical Sequence